Your browser doesn't support javascript.
loading
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience.
Lu, Brian; Ha, David; Shen, Sa; Ferguson Toll, Jessica; Kim, Ailin; Kim, Sarah; Mui, Emily; Deresinski, Stan; Holubar, Marisa; Alegria, William.
Afiliação
  • Lu B; Department of Pharmacy, Stanford Health Care, Stanford, California, USA.
  • Ha D; Department of Quality, Stanford Health Care, Stanford, California, USA.
  • Shen S; Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.
  • Ferguson Toll J; Quantitative Sciences Unit, School of Medicine, Stanford University, Stanford, California, USA.
  • Kim A; Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.
  • Kim S; Department of Pharmacy, Stanford Health Care, Stanford, California, USA.
  • Mui E; Department of Pharmacy, Stanford Health Care, Stanford, California, USA.
  • Deresinski S; Department of Quality, Stanford Health Care, Stanford, California, USA.
  • Holubar M; Division of Infectious Diseases and Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.
  • Alegria W; Department of Quality, Stanford Health Care, Stanford, California, USA.
Open Forum Infect Dis ; 11(6): ofae103, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38887478
ABSTRACT
Combination antifungal therapy for invasive mucormycosis remains controversial and is inconsistently defined in prior studies. In a cohort of patients with immunocompromised status and invasive mucormycosis, we found no difference in 6-week mortality with up-front or salvage combination therapy as compared with monotherapy.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos